About Gaffney Health Services
Clinical Trials at Gaffney Health Services
During the past decade, Gaffney Health Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gaffney Health Services" #1 sponsor was "Celgene" with 2 trials, followed by "Bayer" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Purdue Pharma LP"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gaffney Health Services"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Gaffney Health Services
According to Clinical.Site data, the most researched conditions in "Gaffney Health Services" are
"Crohn Disease" (2 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Low Back Pain" (1 trials). Many other conditions were trialed in "Gaffney Health Services" in a lesser frequency.
Clinical Trials Intervention Types at Gaffney Health Services
Most popular intervention types in "Gaffney Health Services" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "GED-0301" (2 trials), "Kerendia (Finerenone, BAY94-8862)" (1 trials), "Methotrexate" (1 trials) and "Oxycodone/Naloxone Controlled-release" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gaffney Health Services
The vast majority of trials in "Gaffney Health Services" are
6 trials for "All" genders.
Clinical Trials Status at Gaffney Health Services
Currently, there are NaN active trials in "Gaffney Health Services".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Gaffney Health Services,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gaffney Health Services, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".